Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.39% | -4.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.39% | -3.96% | |||
| Cost of Revenue | 0.39% | -10.54% | |||
| Gross Profit | 0.39% | 6.29% | |||
| SG&A Expenses | 0.39% | -27.16% | |||
| Depreciation & Amortization | 0.39% | 9.19% | |||
| Other Operating Expenses | 0.00% | 107.17% | |||
| Total Operating Expenses | 0.39% | -15.31% | |||
| Operating Income | -0.37% | 64.07% | |||
| Income Before Tax | -0.39% | 65.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.39% | 57.74% | |||
| Earnings from Discontinued Operations | -0.60% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.38% | 53.48% | |||
| EBIT | -0.37% | 64.07% | |||
| EBITDA | -0.35% | 83.00% | |||
| EPS Basic | 0.00% | 66.67% | |||
| Normalized Basic EPS | 0.00% | 75.00% | |||
| EPS Diluted | 0.00% | 66.67% | |||
| Normalized Diluted EPS | 0.00% | 75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 42.63% | |||
| Average Diluted Shares Outstanding | 0.00% | 42.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||